Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
UPDATE:
- This class action settlement is paying out as of April 14, 2023.
- Congratulations to everyone who filed a claim and got paid!
Consumers who were prescribed Suboxone could benefit from a $500,000 Federal Trade Commission (FTC) settlement over false advertising and antitrust violations.
The settlement benefits consumers who were prescribed Suboxone oral film between March 1, 2013, and Feb. 28, 2019.
Suboxone is a medication used to treat opioid addiction, according to Drugs.com. The medication comes in a tablet and film form.
According to the FTC, Reckitt Benckiser and Indivior conspired together to maximize Suboxone profits at the expense of consumers. In an attempt to convince more patients to take their branded medication, the companies allegedly deceived patients and doctors with claims that the film version of Suboxone was safer than tablet versions.
To secure their profits from this alleged false advertising, Reckitt Benckiser and Indivior suppressed generic competition by filing “meritless” petitions with the U.S. Food and Drug Administration (FDA), the FTC contends. These petitions reportedly repeated unsupported safety claims about the film version of Suboxone and urged the FDA to reject applications for generic tablet alternatives.
The FTC says these actions caused consumers to pay more for Suboxone when, in a healthy market, they would have otherwise been able to purchase less expensive generic versions of the medication.
In July 2020, Reckitt Benckiser agreed to a $50 million settlement to resolve these claims. Shortly after, Indivior agreed to pay $10 million to resolve the allegations.
In May 2021, the FTC distributed over $59 million to consumers who were prescribed Suboxone. Of this sum, $42 million was sent in the form of 37,212 checks while the remaining $16 million was sent as 14,663 prepaid debit cards. The 51,875 payments averaged $1,139.
With the remaining $500,000 from the settlement fund, the FTC is distributing payments to consumers who submit a valid claim form.
These payments are only available to consumers who contacted the claims administrator after the original 2021 claim deadline and asked to be put on the waitlist for payments. Consumers cannot file a claim if they did not add their name to the waitlist before September 2021, even if they otherwise qualify for payments.
No deadline for exclusion or objection is listed on the settlement website. The Suboxone FTC settlement is not subject to final court approval.
In order to receive a payment from the Suboxone FTC settlement, consumers must submit a valid claim form by Nov. 26, 2022. To file a claim, consumers must use the ID number they received via email or mail.
Who’s Eligible
Consumers who were prescribed Suboxone oral film between 03/01/2013 – 02/28/2019
Potential Award
Varies
Proof of Purchase
No proof of purchase applicable
Claim Form
No claim form applicable
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
11/26/2022
Case Name
Federal Trade Commission v. Indivior, Civil Action No. 20-cv-00036, in the U.S. District Court for the Western District of Pennyslvania
Federal Trade Commission v. Reckitt Benckiser Group PLC, Civil Action No 1:19-CV-00028, in the U.S. District Court for the Western District of Pennsylvania
Final Hearing
N/A
Settlement Website
Claims Administrator
SuboxoneClaimsCenter@jndla.com
1-877-545-0238
Class Counsel
Markus Heinz Meier
US FEDERAL TRADE COMMISSION
Defense Counsel
For Indivior:
Jennifer Scott DeGraw
GENTRY LOCKE RAKES & MOORE
Jonathan Bruce Berman
JONES DAY
For Reckitt Benckiser:
Howard M Shapiro
WILMER CUTLER PICKERING HALE AND DORR LLP
Read About More Class Action Lawsuits & Class Action Settlements:
- RelaDyne employee finger scan $121K class action settlement
- Ron’s Staffing fingerprint time clock $5.4M class action settlement
- Riot Games discrimination $100M class action settlement
- Presidio employees data breach class action lawsuit settlement
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
154 thoughts onSuboxone false advertising, antitrust $500K FTC settlement
I didn’t get an ID ! I’ve been on them since 2013
I did not receive a I D number.
Add me I didn’t get ID card prob cause I moved
Add me please
I didn’t get an ID
I didn’t get an ID and have been on this since 2014. How do I get an ID?
How do I get an id number I was prescribed Suboxone during that time period
Add me
Suboxone pescriping in Warren co Pa . is worse than the opiod addiction doctor here pushes suboxone to people daily .. My daughter was pescibed the pills that are spose tobe safe for prego women well i seen babies go trough withdrawls , I think they should be taken off the Rx list as a safe and effective drug to overcome opiod addiction
Add me
Add me
Add me
how do i get an id number?
How do I get an id number I was prescribed Suboxone during that time period